986 related articles for article (PubMed ID: 25849134)
21. Specificity redirection by CAR with human VEGFR-1 affinity endows T lymphocytes with tumor-killing ability and anti-angiogenic potency.
Wang W; Ma Y; Li J; Shi HS; Wang LQ; Guo FC; Zhang J; Li D; Mo BH; Wen F; Liu T; Liu YT; Wang YS; Wei YQ
Gene Ther; 2013 Oct; 20(10):970-8. PubMed ID: 23636245
[TBL] [Abstract][Full Text] [Related]
22. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix.
Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR
J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294
[TBL] [Abstract][Full Text] [Related]
23. Chimeric antigen receptor-redirected T cells display multifunctional capacity and enhanced tumor-specific cytokine secretion upon secondary ligation of chimeric receptor.
Henderson MA; Yong CS; Duong CP; Davenport AJ; John LB; Devaud C; Neeson P; Westwood JA; Darcy PK; Kershaw MH
Immunotherapy; 2013 Jun; 5(6):577-90. PubMed ID: 23725282
[TBL] [Abstract][Full Text] [Related]
24. Dominant-negative CREB inhibits heparanase functionality and melanoma cell invasion.
Aucoin R; Reiland J; Roy M; Marchetti D
J Cell Biochem; 2004 Oct; 93(2):215-23. PubMed ID: 15368349
[TBL] [Abstract][Full Text] [Related]
25. Photothermal Therapy Promotes Tumor Infiltration and Antitumor Activity of CAR T Cells.
Chen Q; Hu Q; Dukhovlinova E; Chen G; Ahn S; Wang C; Ogunnaike EA; Ligler FS; Dotti G; Gu Z
Adv Mater; 2019 Jun; 31(23):e1900192. PubMed ID: 30916367
[TBL] [Abstract][Full Text] [Related]
26. Alteration of endothelial proteoglycan and heparanase gene expression by high glucose, insulin and heparin.
Han J; Hiebert LM
Vascul Pharmacol; 2013; 59(3-4):112-8. PubMed ID: 23939434
[TBL] [Abstract][Full Text] [Related]
27. Genetic Engineering of T Cells to Target HERV-K, an Ancient Retrovirus on Melanoma.
Krishnamurthy J; Rabinovich BA; Mi T; Switzer KC; Olivares S; Maiti SN; Plummer JB; Singh H; Kumaresan PR; Huls HM; Wang-Johanning F; Cooper LJ
Clin Cancer Res; 2015 Jul; 21(14):3241-51. PubMed ID: 25829402
[TBL] [Abstract][Full Text] [Related]
28. Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors.
Wang Y; Geldres C; Ferrone S; Dotti G
Expert Opin Ther Targets; 2015; 19(10):1339-50. PubMed ID: 26190756
[TBL] [Abstract][Full Text] [Related]
29. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells.
Savion N; Disatnik MH; Nevo Z
J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131
[TBL] [Abstract][Full Text] [Related]
30. A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase.
Lider O; Cahalon L; Gilat D; Hershkoviz R; Siegel D; Margalit R; Shoseyov O; Cohen IR
Proc Natl Acad Sci U S A; 1995 May; 92(11):5037-41. PubMed ID: 7761444
[TBL] [Abstract][Full Text] [Related]
31. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4
de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
J Leukoc Biol; 2007 Nov; 82(5):1289-1300. PubMed ID: 29350861
[TBL] [Abstract][Full Text] [Related]
32. Bioorthogonal Equipping CAR-T Cells with Hyaluronidase and Checkpoint Blocking Antibody for Enhanced Solid Tumor Immunotherapy.
Zhao Y; Dong Y; Yang S; Tu Y; Wang C; Li J; Yuan Y; Lian Z
ACS Cent Sci; 2022 May; 8(5):603-614. PubMed ID: 35647274
[TBL] [Abstract][Full Text] [Related]
33. Relationship of p53 overexpression on cancers and recognition by anti-p53 T cell receptor-transduced T cells.
Theoret MR; Cohen CJ; Nahvi AV; Ngo LT; Suri KB; Powell DJ; Dudley ME; Morgan RA; Rosenberg SA
Hum Gene Ther; 2008 Nov; 19(11):1219-32. PubMed ID: 19848582
[TBL] [Abstract][Full Text] [Related]
34. IL-7 and CCL19 expression in CAR-T cells improves immune cell infiltration and CAR-T cell survival in the tumor.
Adachi K; Kano Y; Nagai T; Okuyama N; Sakoda Y; Tamada K
Nat Biotechnol; 2018 Apr; 36(4):346-351. PubMed ID: 29505028
[TBL] [Abstract][Full Text] [Related]
35. Function from within: Autophagy induction by HPSE/heparanase--new possibilities for intervention.
Ilan N; Shteingauz A; Vlodavsky I
Autophagy; 2015; 11(12):2387-9. PubMed ID: 26571129
[TBL] [Abstract][Full Text] [Related]
36. Heparanase: A Multitasking Protein Involved in Extracellular Matrix (ECM) Remodeling and Intracellular Events.
Masola V; Bellin G; Gambaro G; Onisto M
Cells; 2018 Nov; 7(12):. PubMed ID: 30487472
[TBL] [Abstract][Full Text] [Related]
37. Heparanase Promotes Syndecan-1 Expression to Mediate Fibrillar Collagen and Mammographic Density in Human Breast Tissue Cultured
Huang X; Reye G; Momot KI; Blick T; Lloyd T; Tilley WD; Hickey TE; Snell CE; Okolicsanyi RK; Haupt LM; Ferro V; Thompson EW; Hugo HJ
Front Cell Dev Biol; 2020; 8():599. PubMed ID: 32760722
[TBL] [Abstract][Full Text] [Related]
38. Minicircle DNA-Engineered CAR T Cells Suppressed Tumor Growth in Mice.
Han J; Gao F; Geng S; Ye X; Wang T; Du P; Cai Z; Fu Z; Zhao Z; Shi L; Li Q; Cai J
Mol Cancer Ther; 2020 Jan; 19(1):178-186. PubMed ID: 31582530
[TBL] [Abstract][Full Text] [Related]
39. Thermal Control of Engineered T-cells.
Abedi MH; Lee J; Piraner DI; Shapiro MG
ACS Synth Biol; 2020 Aug; 9(8):1941-1950. PubMed ID: 32786924
[TBL] [Abstract][Full Text] [Related]
40. Immunological quality and performance of tumor vessel-targeting CAR-T cells prepared by mRNA-EP for clinical research.
Inoo K; Inagaki R; Fujiwara K; Sasawatari S; Kamigaki T; Nakagawa S; Okada N
Mol Ther Oncolytics; 2016; 3():16024. PubMed ID: 27909701
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
